Filter
3250
Filtered Results: 3250
Text search:
media
exposure
Featured
Recommendations
307
New Publications
848
Language
Document type
No document type
1835
Studies & Reports
536
Guidelines
468
Manuals
176
Strategic & Response Plan
107
Fact sheets
54
Training Material
32
Situation Updates
24
Infographics
11
Resource Platforms
5
Brochures
1
Online Courses
1
Countries / Regions
India
160
Global
136
Kenya
99
Ethiopia
76
Nigeria
75
Nepal
73
South Africa
67
Western and Central Europe
67
Sierra Leone
59
Liberia
55
Uganda
55
Bangladesh
50
Africa
49
Ghana
47
Tanzania
46
Malawi
45
Zambia
44
Myanmar / Burma
44
Latin America and the Carribbean
42
Rwanda
41
Philippines
40
Syria
39
Ukraine
29
Middle East and North Africa
29
Indonesia
28
Brazil
28
Cambodia
25
East and Southern Africa
25
West and Central Africa
25
Namibia
24
South–East Asia Region
24
Asia
23
Zimbabwe
20
Eastern Europe
20
Lesotho
19
Guinea
17
Congo, Democratic Republic of
17
Mozambique
17
Eastern Europe and Central Asia
16
South Sudan
14
Botswana
12
Senegal
11
Pakistan
11
Yemen
11
Burkina Faso
10
USA
10
Haiti
10
Germany
10
Western Pacific Region
10
Venezuela
10
Thailand
9
Eswatini/ Swaziland
9
Russia
9
Vietnam
9
China
8
Lebanon
7
Peru
7
Colombia
7
Angola
7
Paraguay
7
Somalia
6
Afghanistan
6
Laos
6
Central African Republic
5
Sudan
4
Argentina
4
Sri Lanka
4
Palestine
4
Mali
3
Guinea-Bissau
3
Cameroon
3
Jordan
3
Malaysia
3
Chile
3
Albania
3
Timor Leste/ East Timor
3
Tajikistan
3
Moldova
3
Georgia
3
United Kingdom
3
Spain
3
Côte d’Ivoire / Ivory Coast
2
Niger
2
Iraq
2
Egypt
2
Papua New Guinea
2
Honduras
2
Mexico
2
Other region
2
Bhutan
2
Armenia
2
Canada
2
Iran
2
North America
2
Mauritius
2
Portugal
2
Morocco
1
Turkey
1
Chad
1
Singapore
1
Benin
1
Dominican Republic
1
North Macedonia
1
Serbia
1
Burundi
1
Ecuador
1
Bolivia
1
Libya
1
Madagascar
1
Fiji
1
Southern Africa
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
Gabon
1
Japan
1
France
1
Tunisia
1
South Korea
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1230
Clinical Guidelines
262
Public Health
196
Women & Child Health
146
Key Resources
143
Pharmacy & Technologies
37
Capacity Building
32
Toolboxes
COVID-19
377
HIV
332
Mental Health
243
TB
144
Rapid Response
132
Planetary Health
128
Ebola
88
Conflict
80
AMR
79
NTDs
71
Disability
61
NCDs
58
Caregiver
54
Global Health Education
51
Refugee
47
Natural Hazards
45
Specific Hazards
41
Pharmacy
41
Zika
27
Cholera
17
Polio
13
Health Financing Toolbox
10
Social Ethics
5
Typhoon
1
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The world faces grave consequences from the lack of available mental health services and treatment. Mental illness impacts every country, culture and community, with the World Health Organization (WHO) stating that 10% of the global burden of disease is related to mental, neurological and substance ...
La promotion de la santé et la prévention des maladies nécessitent une action multisectorielle qui renforce les environnements favorables à la santé et oriente les comportements. Au niveau des cantons et des communes, de nombreuses politiques, telles
la protection de la jeunesse, la promotion ...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
As a high-burden neglected tropical disease, soil-transmitted helminth (STH) infections remain a major problem in the world, especially among children under five years of age. Since young children are at high risk of being infected, STH infection can have a long-term negative impact on their life, i...
The World health statistics report is the annual compilation of health and health-related indicators which has been published by the World Health Organization (WHO) since 2005. The 2023 edition reviews more than 50 health-related indicators from the Sustainable Development Goals (SDGs) and WHO’s T...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This report presents findings from research conducted by Economist Impact to assess the health, demographic, social and economic impacts associated with different scenarios for financing the HIV epidemic across 13 selected countries in Sub-Saharan Africa. The sponsorship of UNAIDS towards this repor...
According to most recent data, the world economy grew by 3.1 per cent in 2022. To many, the rebound
suggested that a soft landing was possible in 2023, and that the key problems of the year 2022 – rising
prices, supply-chain disruptions and recession risks – have been addressed. As a result, t...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
